Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Mazzi

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Nature Cancer|October 2, 2023
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivoEirini Giannakopoulou, Madeleine Lehander, Stina Virding Culleton, et al.
Nature Biotechnology|December 7, 2021
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytesMuhammad Ali, Eirini Giannakopoulou, Yingqian Li, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Nature Cancer|October 2, 2023
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivoEirini Giannakopoulou, Madeleine Lehander, Stina Virding Culleton, et al.
Nature Biotechnology|December 7, 2021
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytesMuhammad Ali, Eirini Giannakopoulou, Yingqian Li, et al.
Pageof 2